RET Clinical Trial News and Information

Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET clinical trials.

LCGS vaccine info for EGFR lung cancer
New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

Inherited genetic factors can contribute to EGFR lung cancer risk, but the role of rare…
September 29, 2026
cancer vaccine success BioNTech
BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

A new Phase I study, 53% of patients with available tissue had a major pathological…
September 24, 2026
Dr Alexandre Drilon Ret positive lung cancer researcher
New Study: Insights into the Role of Chemotherapy and Immunotherapy in RET-Positive Lung Cancer

New Study: Insights into the Role of Chemotherapy and Immunotherapy in RET-Positive Lung Cancer

A new study led by Dr. Alexander Drilon, member of HLP’s Scientific Advisory Board, finds…
September 14, 2026
new clinical trial for NSCLC
New Clinical Trial Evaluating Ivonescimab in Advanced NSCLC

New Clinical Trial Evaluating Ivonescimab in Advanced NSCLC

A new clinical trial at Massachusetts General Hospital is testing whether a dual-action immunotherapy can…
September 10, 2026
RET cancer vaccine trial
BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

Exciting news for the RET community! BioNTech’s BNT116 mRNA cancer vaccine trial now enables combination…
April 27, 2026
ARROW clinical trial ret lung cancer findings
Pralsetinib (GAVRETO) for RET+ Lung Cancer: Final ARROW Trial Results

Pralsetinib (GAVRETO) for RET+ Lung Cancer: Final ARROW Trial Results

The findings confirm what many in the RET+ community have been hoping to see: durable…
April 24, 2026
Lilly pharmaceutical clinical trial
Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Eli Lilly and Company announced positive results from the Phase 3 LIBRETTO-432 clinical trial evaluating…
February 17, 2026
POISE cancer study
Join the POISE study at Massachusetts General Hospital

Join the POISE study at Massachusetts General Hospital

Join the study! Researchers have developed POISE, a short program combining palliative and survivorship care…
October 23, 2025
RET clinical study phase 2 ellipses
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Ellipses’ next generation selective RET inhibitor EP0031 advances to Phase 2 clinical trials in the…
July 10, 2025
clinical trial enrollment, informed consent, institutional review board and clinical research studies
Navigating The Lung Cancer Clinical Trial Enrollment Process

Navigating The Lung Cancer Clinical Trial Enrollment Process

Navigating lung cancer clinical trials can be daunting, but it’s a path to cutting-edge care…
December 9, 2024
Randomized clinical trials and research ethics for clinical cancer trials
Ethical Considerations in RET Lung Cancer Clinical Trials

Ethical Considerations in RET Lung Cancer Clinical Trials

RET lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let’s explore…
October 28, 2024
phase I trial, phase ii trial, phase iii trial for cancer patients
From Safety to Approval: RET Lung Cancer Clinical Trial Phases

From Safety to Approval: RET Lung Cancer Clinical Trial Phases

The clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are…
September 16, 2024
non small cell lung cancer clinical trials near you
Why Should You Participate in Lung Cancer Clinical Trials?

Why Should You Participate in Lung Cancer Clinical Trials?

Lung cancer clinical trials offer the potential for access to cutting-edge treatments and therapies that…
July 22, 2024
harmonic never smoker lung cancer trial
The Harmonic™ Clinical Trial for Never Smokers

The Harmonic™ Clinical Trial for Never Smokers

New clinical trial for never smokers: The Harmonic™ clinical trial The Harmonic™ clinical trial is…
March 9, 2024
lung cancer research
New clinical trial testing amivantamab

New clinical trial testing amivantamab

New clinical trial testing amivantamab for patients who progressed on RET therapies:  A Phase 1…
October 8, 2023
Match to a clinical trial